List of SBIR/STTR awards granted to Recombinant Technologies LLC
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Recombinant Technologies LLC in June, 2019 for $639,601.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AG057327-02 | Phase II | 639,601 | June 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Recombinant Technologies LLC in September, 2017 for $148,491.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AG057327-01 | Phase I | 148,491 | September 1, 2017 | |||||||
A SBIR Phase II contract was awarded to Recombinant Technologies LLC in May, 2016 for $1,696,216.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AG050336-01 | Phase II | 1,696,216 | May 15, 2016 | |||||||
A SBIR Phase I contract was awarded to Recombinant Technologies LLC for $149,800.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AG023457-01 | Phase I | 149,800 | ||||||||
A SBIR Phase I contract was awarded to Recombinant Technologies LLC for $274,940.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AG034712-01A1 | Phase I | 274,940 | ||||||||
A SBIR Phase II contract was awarded to Recombinant Technologies LLC for $674,976.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AG023457-02 | Phase II | 674,976 | ||||||||
A SBIR Phase I contract was awarded to Recombinant Technologies LLC for $351,027.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AG030866-01A1 | Phase I | 351,027 | ||||||||
A SBIR Phase I contract was awarded to Recombinant Technologies LLC for $122,437.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 122,437 | |||||||||
A SBIR Phase II contract was awarded to Recombinant Technologies LLC in September, 2023 for $806,673.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AG057327-04 | Phase II | 806,673 | September 30, 2023 |
